exciplex® is a 308 nm excimer light developed by CLARTEIS for the treatment of vitiligo, alopecia areata, psoriasis, atopic dermatitis, and mycosis fungoides. Its monochromatic wavelength has demonstrated high efficacy in the treatment of these skin conditions. By inducing apoptosis of deregulated T-cells, 308 nm excimer light helps modulate local immune responses, reduce inflammatory activity and, in conditions as vitiligo, support repigmentation.
exciplex® allows dermatologists to deliver controlled doses with high accuracy. It helps them precisely targeted skin while minimizing exposure to surrounding healthy tissues.
exciplex® is particularly suitable for sensitive and hard-to-reach areas, as 308 nm UVB acts primarily within the epidermis. Treatment sessions are fast, typically lasting less than five minutes, providing an additional benefit for both practitioners and patients.
The clinical benefits of 308 nm excimer light are supported by more than 250 published clinical studies.